ADC Therapeutics SA (ADCT) Stock Price, Quote, News & History

ADCTNYSE
$1.36
0.043.03%
At close: Sep 4, 5:00 PM EST
$1.36
N/A
After Hours: Sep 4, 6:41 PM EST

ADC Therapeutics (ADCT) Stock Price, Quote, News & History | Benzinga

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change

Cash Flows

Operating Cash Flow (TTM)
-102.27M
Investing Cash Flow (TTM)
627.00K
Financing Cash Flow (TTM)
56.21M
Free Cash Flow (TTM)
-102.30M
Capital Expenditure (TTM)
-32.00K
Net Change in Cash (TTM)
-45.43M

Analyst Trends and Forecast

1
Mar
2
May
1
Jun
1
Aug
Buy
Hold
Sell
Strong Sell

Analyst Rating and Forecast

12345
3.3
Hold
Strong Buy
Buy
Hold
Sell
Strong Sell

Valuation Metrics

Enterprise Value
$72.08M
PE Ratio (TTM)
-
PE Ratio (FWD)
-
PEG Ratio (TTM)
-
PS Ratio (TTM)
2.47
PB Ratio (TTM)
-
Earnings Yield % (TTM)
-43.94%
Earnings Yield % (FWD)
-43.18%
EV / EBITDA (TTM)
-
Price / EBITDA (TTM)
-
Price / Free Cash Flow (TTM)
-
Book Value / Share
-$1.79

Company Debt

Total Debt
$116.62M
LT Debt
$110.44M
LT Debt Issuance (TTM)
-
LT Debt Repayment (TTM)
-
Total Cash
$219.11M
Debt to Equity
-
Issuance of Debt (TTM)
-
Repayment of Debt (TTM)
-

Key Statistics

Open
$1.30
Close
$1.36
Volume / Avg.
1.48M / 2.04M
Day Range
$1.30 - $1.37
52 Wk Range
0.78 - 4.98
Market Cap
$173.63M
P/E Ratio
-
Dividend Yield
-
Exchange
NYSE
RSI
66
Short Interest
5.7%
Days to Cover
6.3

About

Sector
Health Care
Industry
Biotechnology
ADC Therapeutics SA is a commercial-stage oncology-focused biotechnology company. It is involved in the development of antibody-drug conjugates for patients suffering from hematological malignancies and solid tumors. The company's FDA-approved and ma...
Show More
Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

FAQ

Q

How do I buy ADC Therapeutics (ADCT) stock?

A

You can purchase shares of ADC Therapeutics (NYSE:ADCT) through any online brokerage.

View our list of the best stock brokerages

Q

Who are ADC Therapeutics (ADCT) competitors?

Q

What is the forecast, or price target, for ADC Therapeutics (ADCT) stock?

A

ADC Therapeutics has a consensus price target of $5.75.

Q

What is the current price for ADC Therapeutics (ADCT)?

A

The stock price for ADC Therapeutics (NYSE: ADCT) is $1.36 last updated September 4, 2026 at 6:41 PM EDT.

Q

Does ADC Therapeutics (ADCT) pay a dividend?

A

There are no upcoming dividends for ADC Therapeutics.

Q

When is ADC Therapeutics (NYSE:ADCT) reporting earnings?

A

ADC Therapeutics does not have any upcoming earnings scheduled.

Q

Is ADC Therapeutics (ADCT) going to split?

A

There is no upcoming split for ADC Therapeutics.

Q

What sector and industry does ADC Therapeutics (ADCT) operate in?

A

ADC Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NYSE.